Noopur Raje
Director, Multiple Myeloma Program / Professor of Medicine at Harvard Medical School
Schools
- Harvard Medical School
Links
Biography
Harvard Medical School
Dr. Noopur Raje received her medical degree from B.J. Medical College, Pune University, India. She has trained in internal medicine at Massachusetts General Hospital (MGH) and has completed a fellowship in hematology and medical oncology at the Dana-Farber Cancer Institute, Boston. Dr. Raje has a joint faculty appointment at MGH and Dana-Farber Cancer Institute. She is a professor of medicine at Harvard Medical School and is the director of the Multiple Myeloma Program, Medical Oncology, at MGH. As a hematologist/oncologist at MGH, Dr. Raje’s primary focus is in multiple myeloma and related research. Her laboratory focuses on bone biology and the development of novel therapeutics for multiple myeloma, as well as identifying and validating novel targets and translating them into clinical trials.
Dr. Raje is a member of the American Medical Association, America Society of Hematology, American Society of Clinical Oncology, and American Association of Cancer Research, she is also an ad hoc reviewer for several journals including Blood, Clinical Cancer Research, Leukemia, and the American Journal of Hematology. Dr. Raje is the recipient of several awards and has published extensively in the field of multiple myeloma research. Her hope is to continue pursing laboratory and clinical research in the area of multiple myeloma with the goal of translating her efforts to the improvement of patients’ lives.
Departments, Centers, & Programs:
- Cancer Center
- Hematology
- Multiple Myeloma
- Hematology/Oncology
Medical Education
- MD, B. J. Medical college
- MBBS, Sassoon General Hospital
- Residency, Massachusetts General Hospital
- Fellowship, Dana Farber Cancer Institute
- Fellowship, Tata Memorial Cancer Institute
Videos
Dr. Raje Discusses the Impact of bb2121in Myeloma
Dr. Raje on Treatment Approaches for Relapsed/Refractory Myeloma
Dr Noopur Raje, COVID-19 Experience at Massachusetts General Hospital
Dr. Raje on Quadruplet Regimens in Myeloma
Dr. Raje on the Efficacy of Belantamab Mafodotin in Multiple Myeloma
Dr. Raje on the Rationale for CAR T-Cell Therapy in Multiple Myeloma
Advances in Multiple Myeloma and Waldenstrom’s Macroglobulinemia including COVID-19 Update
Dr. Raje Discusses the Tolerability of bb2121 in Myeloma
Noopur Raje on bb21217 in Myeloma
Dr. Raje on Key Challenges Faced in Multiple Myeloma
Dr. Raje on bb21217 in Multiple Myeloma
Current CAR-T climate in multiple myeloma
Dr. Raje on Future Research With BiTEs in Multiple Myeloma
Preclinical Data Supporting Use of CAR T-Cell Therapy in Multiple Myeloma
Key updates from the IMW 2021 meeting
Dr. Noopur Raje Discusses Anti-CD38 Antibodies in Myeloma
Patient-Focused Care Built on Trust with Noopur Raje, MD
Read about executive education
Other experts
Looking for an expert?
Contact us and we'll find the best option for you.